Advil-maker Haleon boosts sales by targeting consumers on weight-loss drugs
Advil maker Haleon is capitalizing on the GLP-1 boom, boosting sales of products that combat weight loss drugs side effects with strategic store placement.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.